[1]
Hale, MD, M.E., Wallace, MD, M.S., Taylor, MD, D.R., Kutch, MS, M. and Nalamachu, MD, S. 2012. Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: Pooled analysis of 13 studies. Journal of Opioid Management. 8, 5 (Sep. 2012), 299–314. DOI:https://doi.org/10.5055/jom.2012.0130.